INTERNATIONAL Turkey: RSA partners with FarmaCity
28 March 2012
Global life science executive search and interim management firm RSA will be working on placements in Turkey alongside life sciences executive recruiter FarmaCity, after the two established a “formal business relationship”.
Fri, 17 Feb 2012
Global life science executive search and interim management firm RSA will be working on placements in Turkey alongside life sciences executive recruiter FarmaCity, after the two established a “formal business relationship”.
RSA chief executive Nick Stephens tells Recruiter that the move comes after three years of informal relationship between the two firms. The two now have a financial interest in each other, and FarmaCity managing director Esra Guney Baris will attend every other RSA global leadership team meeting.He says that in a “pure relationship market”, it was important for RSA to partner with a local firm that was already “very well known”.
He adds that he had been surprised initially on finding that “Turkey’s pharmaceutical market was actually bigger than India’s”, with Intercontinental Medical Statistics (IMS) data showing it as the 10th fastest-growing “pharmerging” country in terms of pharmaceutical organisations’ sales activities.
Guney Baris says: “Istanbul is the gateway to the CIS (Commonwealth of Independent States – former Soviet Republic) and Middle East markets. Our job will be to help RSA manage those clients and relationships. The partnership means that we can provide our clients with a much wider perspective as well as a global executive search facility.”
Global life science executive search and interim management firm RSA will be working on placements in Turkey alongside life sciences executive recruiter FarmaCity, after the two established a “formal business relationship”.
RSA chief executive Nick Stephens tells Recruiter that the move comes after three years of informal relationship between the two firms. The two now have a financial interest in each other, and FarmaCity managing director Esra Guney Baris will attend every other RSA global leadership team meeting.He says that in a “pure relationship market”, it was important for RSA to partner with a local firm that was already “very well known”.
He adds that he had been surprised initially on finding that “Turkey’s pharmaceutical market was actually bigger than India’s”, with Intercontinental Medical Statistics (IMS) data showing it as the 10th fastest-growing “pharmerging” country in terms of pharmaceutical organisations’ sales activities.
Guney Baris says: “Istanbul is the gateway to the CIS (Commonwealth of Independent States – former Soviet Republic) and Middle East markets. Our job will be to help RSA manage those clients and relationships. The partnership means that we can provide our clients with a much wider perspective as well as a global executive search facility.”
